Xilio Therapeutics, Inc.
XLO
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$8.51
FAIR PRICE
$12.40
MARGIN
$3.89
COMING SOON
Get notified when XLO's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Rene Russo
COUNTRY
US
HEADQUARTERS
Waltham
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate XLO's fair price
Xilio Therapeutics, Inc.'s fair price of $12.40 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $8.51, XLO trades 45.7% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting XLO's risk profile.
RELATIVE · 30%
Comparing XLO's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for XLO, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate XLO's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for XLO.
Explore on BuliosFAQ
What is the fair price of XLO?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Xilio Therapeutics, Inc. is $12.40. At the current market price of $8.51, XLO trades 45.7% below its calculated fair value.
Is XLO overvalued or undervalued?+
Xilio Therapeutics, Inc. is currently undervalued based on our valuation model. The stock trades at $8.51, which is 45.7% below the fair price of $12.40. The P/E ratio of 2.2x is a key metric in the valuation.
How often is XLO's fair price updated?+
We update fair price calculations for XLO daily after market close. The current fair price of $12.40 incorporates the latest market data and sector multiples.
What factors affect XLO's fair price calculation?+
XLO's fair price of $12.40 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 2.2x, ROE of 0.0%.
Is XLO a good buy right now?+
At $8.51, XLO trades 45.7% below our fair value estimate of $12.40. The stock is currently undervalued. ROE stands at 0.0% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does XLO pay dividends?+
XLO does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.